Fed Decriminalization of Cannabis Could Spark New Pot Stock Boom
With Democrats now controlling both houses of Congress and the executive branch, cannabis decriminalization on the federal level could be months away. This could result in established Washington State weed companies being able to market across state lines -- setting off a bidding war for quality stocks at reasonable prices.
Get All the Details on #1 Stock

DFFN Insider Trading (Diffusion Pharmaceuticals)

Insider Ownership Percentage: 1.40%
Insider Buying (Last 12 Months): $19,999.46
Insider Selling (Last 12 Months): $0.00

Diffusion Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Diffusion Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Diffusion Pharmaceuticals Share Price & Price History

Current Price: $0.42
Price Change: Price Increase of +0.0321 (8.22%)
As of 11/29/2021 12:52 PM ET

This chart shows the closing price history over time for DFFN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Cyber Monday Special: Could 12/1 be the most profitable event in crypto history?
Man voted "#1 Most Trusted Crypto Expert" shares his latest buy recommendation.
Click For Special

Diffusion Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/13/2021Jane H. HollingsworthDirectorBuy32,786$0.61$19,999.4632,786View SEC Filing Icon  
11/16/2020Robert Joseph Jr. CobuzziCEOBuy14,000$0.66$9,240.0014,000View SEC Filing Icon  
11/16/2020William Robert ElderInsiderBuy10,000$0.67$6,700.0010,000View SEC Filing Icon  
See Full Table
Insider Selling at Diffusion Pharmaceuticals?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Diffusion Pharmaceuticals and related companies.

SEC Filings (Institutional Ownership Changes) for Diffusion Pharmaceuticals (NASDAQ:DFFN)

9.79% of Diffusion Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at DFFN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Diffusion Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/16/2021Citadel Advisors LLC116,895$60K0.0%-22.7%0.115%Search for SEC Filing on Google Icon
11/12/2021Renaissance Technologies LLC1,125,502$0.57M0.0%-18.2%1.104%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC858,408$0.44M0.0%+6.7%0.842%Search for SEC Filing on Google Icon
9/17/2021Virtu Financial LLC285,621$0.21M0.0%+86.1%0.280%Search for SEC Filing on Google Icon
8/17/2021Citadel Advisors LLC151,158$0.11M0.0%N/A0.148%Search for SEC Filing on Google Icon
8/16/2021State Street Corp459,615$0.34M0.0%N/A0.451%Search for SEC Filing on Google Icon
8/13/2021Renaissance Technologies LLC1,375,579$1M0.0%-24.6%1.350%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC804,290$0.59M0.0%+14.9%0.789%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.4,606,967$3.36M0.0%+11.8%4.521%Search for SEC Filing on Google Icon
5/19/2021Virtu Financial LLC153,464$0.14M0.0%N/A0.151%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC334,064$0.31M0.0%N/A0.328%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC1,824,839$1.67M0.0%-35.6%1.791%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp200,949$0.18M0.0%+86.2%0.197%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC700,038$0.64M0.0%+173.8%0.687%Search for SEC Filing on Google Icon
5/12/2021UBS Group AG112,927$0.10M0.0%+1,782.4%0.111%Search for SEC Filing on Google Icon
5/11/2021Wilbanks Smith & Thomas Asset Management LLC43,868$40K0.0%N/A0.043%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.2,044,449$1.88M0.0%+146.2%2.006%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC2,832,739$2.25M0.0%-5.2%4.425%Search for SEC Filing on Google Icon
12/11/2020Virtu Financial LLC155,827$0.13M0.0%+164.2%0.243%Search for SEC Filing on Google Icon
11/4/2020Raymond James Financial Services Advisors Inc.40,000$34K0.0%N/A0.063%Search for SEC Filing on Google Icon
8/17/2020Jane Street Group LLC115,741$0.11M0.0%N/A0.181%Search for SEC Filing on Google Icon
8/7/2020Virtu Financial LLC58,971$57K0.0%N/A0.122%Search for SEC Filing on Google Icon
7/31/2020UBS Group AG31,302$31K0.0%-49.6%0.065%Search for SEC Filing on Google Icon
7/30/2020HCR Wealth Advisors40,000$38K0.0%N/A0.083%Search for SEC Filing on Google Icon
5/11/2020Acadian Asset Management LLC378,712$0.12M0.0%+52.5%0.968%Search for SEC Filing on Google Icon
2/20/2020Geode Capital Management LLC251,163$0.12M0.0%+2,396.7%0.752%Search for SEC Filing on Google Icon
2/13/2020Renaissance Technologies LLC758,292$0.35M0.0%+797.7%2.269%Search for SEC Filing on Google Icon
2/10/2020Barclays PLC153,448$71K0.0%N/A0.459%Search for SEC Filing on Google Icon
2/6/2020Acadian Asset Management LLC248,311$0.11M0.0%+1,360.0%0.743%Search for SEC Filing on Google Icon
8/20/2019Anson Funds Management LP327,381$0.93M0.5%N/A6.980%Search for SEC Filing on Google Icon
8/14/2019Vanguard Group Inc.39,424$0.11M0.0%-19.9%1.167%Search for SEC Filing on Google Icon
8/8/2019Acadian Asset Management LLC17,008$48K0.0%N/A0.503%Search for SEC Filing on Google Icon
8/6/2019Wells Fargo & Company MN149,875$0.43M0.0%N/A4.435%Search for SEC Filing on Google Icon
2/14/2019Two Sigma Investments LP32,176$64K0.0%N/A0.953%Search for SEC Filing on Google Icon
1/16/2019Virtu Financial LLC18,342$37K0.0%-55.8%0.543%Search for SEC Filing on Google Icon
1/1/2019Vanguard Group Inc894,732$0.39M0.0%-2.8%26.471%Search for SEC Filing on Google Icon
5/11/2018Swift Run Capital Management LLC2,508,017$1.37M1.0%+261.8%4.963%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Diffusion Pharmaceuticals logo
Diffusion Pharmaceuticals, Inc. is a clinical stage company, which engages in the development of treatment for life threatening conditions. It offers Trans Sodium Crocetinate. The company was founded by David G. Kalergis and John L. Gainer in 2001 and is headquartered in Charlottesville, VA.
Read More on Diffusion Pharmaceuticals

Today's Range

Now: $0.42
Low: $0.39
High: $0.49

50 Day Range

MA: $0.46
Low: $0.36
High: $0.52

52 Week Range

Now: $0.42
Low: $0.35
High: $1.85

Volume

298,652 shs

Average Volume

3,167,663 shs

Market Capitalization

$43.06 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.38

Who are the company insiders with the largest holdings of Diffusion Pharmaceuticals?

Diffusion Pharmaceuticals' top insider shareholders include:
  1. Jane H Hollingsworth (Director)
  2. Robert Joseph Jr Cobuzzi (CEO)
  3. William Robert Elder (Insider)

Who are the major institutional investors of Diffusion Pharmaceuticals?

Diffusion Pharmaceuticals' top institutional investors include:
  1. Renaissance Technologies LLC — 1.10%
  2. Geode Capital Management LLC — 0.84%
  3. Citadel Advisors LLC — 0.11%

Which institutional investors are selling Diffusion Pharmaceuticals stock?

During the last quarter, DFFN stock was sold by these institutional investors:
  1. Renaissance Technologies LLC
  2. Citadel Advisors LLC

Which institutional investors are buying Diffusion Pharmaceuticals stock?

During the previous quarter, DFFN stock was bought by institutional investors including:
  1. Geode Capital Management LLC
In the previous year, these company insiders have bought Diffusion Pharmaceuticals stock:
  1. Jane H Hollingsworth (Director)
  2. Robert Joseph Jr Cobuzzi (CEO)
  3. William Robert Elder (Insider)
Breaking News Just Announced
This tiny telehealth stock is up over 50% in the past month.
Put it on your watchlist now